Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Myelofibrosis Battle: Novartis Vs. Sanofi
Seeking Alpha
Tue, 09/10/13 - 04:25 pm
Tags:
Novartis, Sanofi, myelofibrosis, Jakafi, Incyte, SAR302503
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Fri, 09/6/13 - 09:12 am
Tags:
Incyte, JAK inhibitors, Jakafi, myelofibrosis
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
Tags:
biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 08/24/13 - 11:46 am
Tags:
Incyte, Novartis, Astex, Pacific Biosciences
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Sat, 08/24/13 - 11:42 am
Tags:
Incyte, Jakafi, pancreatic cancer
Biotech Buyouts: Who's Next?
Motley Fool
Thu, 08/22/13 - 05:35 pm
Tags:
M&A, ONYX Pharmaceuticals, Amgen, Seattle Genetics, Medivation, Incyte
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Tags:
Incyte, JAK inhibitors, Jakafi, pancreatic cancer
Incyte pancreatic cancer drug improves survival in mid-stage trial
Reuters
Wed, 08/21/13 - 10:18 am
Tags:
Incyte, pancreatic cancer, Jakafi
Is This Myelofibrosis Drug a Blockbuster?
Motley Fool
Sat, 08/17/13 - 10:36 am
Tags:
myelofibrosis, Jakafi, Incyte
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thu, 08/15/13 - 11:48 am
Tags:
Novartis, M&A, Biomarin, Incyte
3 Sources Of Revenue For Incyte
Seeking Alpha
Thu, 06/27/13 - 12:51 am
Tags:
Incyte, Gilead, Eli Lilly, Novartis, Sanofi
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Tags:
Humira, AbbVie, Galapagos, GLPG0634, Chron's Disease, Incyte, Eli Lilly, Pfizer, rheumatoid arthritis
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire
Sun, 06/16/13 - 11:33 am
Tags:
Incyte, clinical trials, Jakafi, myelofibrosis
Lilly says arthritis pill effective in mid-stage study
Reuters
Thu, 06/13/13 - 10:45 am
Tags:
Eli Lilly, Incyte, baricitinib, rheumatoid arthritis
Incyte Jakafi outlook still positive after label revisions, says Oppenheimer
Yahoo/Fly on the Wall
Thu, 06/13/13 - 10:31 am
Tags:
Incyte, Jakafi
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
Tags:
biotech, Alkermes, Celgene, AstraZeneca, Coronado Biosciences, Dendreon, Incyte, Isis Pharmaceuticals, JNJ, Eli Lilly, Merck, Novavax, Novartis, Pfizer, Sangamo BioSciences, Pharmacyclics
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Incyte Corporation
Yahoo/BusinessWire
Sat, 04/6/13 - 10:52 am
Tags:
Incyte, lawsuits
Incyte discloses patient treated with ruxolitinib develops PML
The Fly on the Wall
Mon, 03/18/13 - 10:56 am
Tags:
Incyte, PML, ruxolitinib, Jakafi
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Incyte Corporation
Yahoo/BusinessWire
Sun, 03/17/13 - 11:39 am
Tags:
lawsuits, Incyte
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thu, 02/28/13 - 11:35 am
Tags:
Jakafi, Incyte, myelofibrosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.